The antibacterial drugs market

Article Abstract:

Big pharmas view the development of antibacterial drugs as increasingly unattractive due to short antibacterial drug lifecycles, which increases the risk to developers, restricts sales growth, and prioritizes the need for intensive lifecycle-management strategies. All of these factors affected the growth rate in several major pharma markets, which has slowed to a compound annual growth rate (CAGR) of just 5% from 2001-2005.

Product development, Sales & consumption, Pharmaceutical Preparation Manufacturing, Management dynamics, Pharmaceutical preparations, Bacteriostats, Management, Pharmaceutical industry, Antibacterial agents, Company business management, Market size

---

Virtual models best live cells at predicting biology

Article Abstract:

Computer programs of virtual cells are developed that mimic the complex biology of real organisms and provide perfect reproducibility. This is a tool for people in the laboratory to help them organize their experimental data and make predictions.

Science & research, Research, Medical microbiology, Biological complexity

---

Similar abstracts:

• Abstracts: Relationship between market competition and the activities and attitudes of medical school faculty. Resident physicians' preparedness to provide cross-cultural care
• Abstracts: The hard old days. Starched collars and starch baths. Kettles strictly forbidden
• Abstracts: The effect of an organisational model on the standard of care. Nurses win 100m pounds sterling to fund ongoing training needs
• Abstracts: Consent: Obtaining permission to care. Should nurses be allowed to diagnose?
• Abstracts: Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistanse testing

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.